ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VOY Voyager Life plc

4.375
0.00 (0.00%)
24 May 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Voyager Life plc AQSE:VOY Aquis Stock Exchange Ordinary Share GB00BLD3FF28
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.375 2.00 4.75 4.375 3.375 4.375 0.00 16:29:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Voyager Life PLC Voyager extends reach with pharmacy group deal (8353E)

12/07/2021 7:00am

UK Regulatory


Voyager Life (AQSE:VOY)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Voyager Life Charts.

TIDMVOY

RNS Number : 8353E

Voyager Life PLC

12 July 2021

12 July 2021

Voyager Life plc

("Voyager" or "the Company")

Voyager extends sales reach with independent pharmacy group deal

Voyager Life plc, the health and wellness company established to supply high-quality Cannabidiol (CBD) and hemp seed oil products announces that it has been appointed as a preferred supplier to independent pharmacy group Inphaserve.

Inphaserve Independent Pharmacy Buying & Support Group serves the needs of more than 30 independent pharmacists in Scotland and England by negotiating supply contracts on their behalf. The agreement will add Voyager to Inphaserve's list of approved suppliers, allowing the Company to share its marketing materials with Inphaserve's network.

Voyager's products are currently available in over 40 independent retail stores in Scotland and on over 20 third-party websites, including popular online platforms Amazon, eBay and Etsy.

The benefits of the Company's rapidly expanding distribution network are already being seen with sales in June 2021 four times that of May 2021. Voyager's hemp range for pets is proving particularly popular and the Company intends to continue to expand its product lines for this segment over the summer.

The Inphaserve agreement further evidences Voyager 's belief that a significant opportunity exists in the CBD sector as a result of the expected growth of the market, as CBD becomes more mainstream and the regulatory environment for CBD products in the UK develops further.

Nick Tulloch, CEO of Voyager, said: "This is an important new deal for Voyager with a partner that immediately recognised the quality of our products. We look forward to working with Inphaserve to distribute our CBD and hemp products across their network.

"Post-IPO, the Company has a cash balance of circa GBP2 million and is well positioned to build a diverse and robust demand pipeline of sales.

"Forthcoming product releases and the opening of our store in St Andrews this month provides further opportunities for us to continue to increase our sales. Alongside these new products, we will also be updating our branding and upgrading our website in the coming months."

-ENDS-

About Voyager

Voyager was founded in November 2020 and listed on the Aquis stock exchange on 30 June 2021. The Company offers a range of health and wellness products containing CBD and hemp seed oil. Products include oils, "gummies" (chewable sweets), bath and skincare products and hemp-based products for pets, which are available online through the company's website www.voyagercbd.com , through independent stores and more than 20 third-party websites, including popular online platforms Amazon, eBay and Etsy.

Enquiries:

 
 Voyager Life plc 
 Nick Tulloch                            01738 505 130 / nick@voyagerlife.uk 
 
 Charlotte Street Partners (Financial 
  Communications) 
 David Gaffney                           +44 (0) 7854 609 998 / david.gaffney@charlottestpartners.co.uk 
 Tom Gillingham                          +44 (0) 7741 659 021 / tom.gillingham@charlottestpartners.co.uk 
 Andrew Wilson                           +44 (0)7810 636 995 / andrew@charlottestpartners.co.uk 
 
 Cairn Financial Advisers LLP (AQSE 
  Corporate Adviser) 
 Liam Murray or Ludovico Lazzaretti      +44 (0) 20 72130 880 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXSFAFIFEFSEDW

(END) Dow Jones Newswires

July 12, 2021 02:00 ET (06:00 GMT)

1 Year Voyager Life Chart

1 Year Voyager Life Chart

1 Month Voyager Life Chart

1 Month Voyager Life Chart

Your Recent History

Delayed Upgrade Clock